Last reviewed · How we verify

NCT03906513

Evaluation of the Efficacy of OMK2 in Recovering Corneal Neural Damage in Patients With Diabetes

Completed NA Last updated 9 May 2019
What this trial tests

NA trial testing OMK2 in Cornea in 30 participants. Completed in 17 January 2019.

Timeline
3 May 2017
Primary endpoint
3 May 2017
17 January 2019

Quick facts

Lead sponsorUniversity of Milan
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment30
Start date3 May 2017
Primary completion3 May 2017
Estimated completion17 January 2019
Sites1 location across Italy

Drugs / interventions tested

Conditions studied

Sponsor

University of Milan

Who can join

Adults 18 to 90, any sex, with Cornea. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This will be a single-centre, randomized, pilot study. 30 patients with diabetes who previously had received Argon laser photocoagulation will be enrolled.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Topical citicoline and vitamin B12 versus placebo in the treatment of diabetes-related corneal nerve damage: a randomized double-blind controlled trial.
    Fogagnolo P, Melardi E, Tranchina L, Rossetti L. · · 2020 · cited 13× · PMID 32738875 · DOI 10.1186/s12886-020-01584-w
  2. Topical citicoline and vitamin B12 versus placebo in the treatment of diabetes-related corneal nerve damage: a randomized double-blind controlled trial.
    Fogagnolo P, Melardi E, Tranchina L, Rossetti L. · · 2020 · DOI 10.21203/rs.2.24135/v2

Verify or expand the search:

Other recruiting trials for Cornea

Currently open trials in the same condition.

Other University of Milan trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03906513.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing